COVID-19 and hypercoagulability in the outpatient setting
- 1 August 2020
- journal article
- editorial
- Published by Elsevier BV in Thrombosis Research
- Vol. 192, 122-123
- https://doi.org/10.1016/j.thromres.2020.05.031
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Thromboinflammation and the hypercoagulability of COVID-19Journal of Thrombosis and Haemostasis, 2022
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and FollowJournal of the American College of Cardiology, 2020
- Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 PneumoniaThe Journal of Infectious Diseases, 2020
- Hematological findings and complications of COVID‐19American Journal of Hematology, 2020
- Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, ItalyThrombosis Research, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- The role of IL-6, IL-8 and MCP-1 and their promoter polymorphisms IL-6 -174GC, IL-8 -251AT and MCP-1 -2518AG in the risk of venous thromboembolism: A case-control studyThrombosis Research, 2011
- A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction ScoreJournal of Thrombosis and Haemostasis, 2010
- Venous Thromboembolism in the Outpatient SettingArchives of Internal Medicine, 2007
- Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysisBMJ, 2003